Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Woldemussie; Elizabeth
Address:
Laguna Niguel, CA
No. of patents:
17
Patents:












Patent Number Title Of Patent Date Issued
6465464 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury October 15, 2002
The present invention provides a method of providing neuroprotection to a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on its nerve cells an effective amount of a compound of formula I to inhibit or prevent nerve cell injury or de
6410544 Cholinergic agents in the treatment of presbyopia June 25, 2002
A method for increasing or decreasing parasympathetic/cholinergic/ciliary tonic contraction in order to restore the resting portion of the eye and allow normal positive and negative accommodation includes administering to a myopic or hyperopic presbyope.
6291466 Cholinergic agents in the treatment of presbyopia September 18, 2001
A method for increasing or decreasing parasympathetic/cholinergic/ciliary tonic contraction in order to restore the resting portion of the eye and allow normal positive and negative accommodation includes administering to a presbyopic subject an effective amount of a muscarinic agent.
6248741 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury June 19, 2001
The present invention provides a method of providing neuroprotection to a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on its nerve cells an effective amount of a compound of formula I to inhibit or prevent nerve cell injury or de
6194415 Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury February 27, 2001
The present invention provides a method of protecting the optic or retinal nerve cells of a mammal comprising administering to said mammal suffering from or at risk of suffering a noxious action on said nerve cells an effective amount of a compound of formula I to inhibit or prevent nerv
6164282 Methods for restoring and/or enhancing accommodation in pseudo phakia December 26, 2000
A method for increasing the amount of accommodation in an eye of a mammal which eye includes an artificial intraocular lens. The method provides for administering to the mammal the amount of a muscarinic agent necessary to restore tonic accommodation.
6077839 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobu June 20, 2000
Ophthalmic compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by topically administering to the mammalian eye the ophthalmic composition of the invention which contains as the active ingredient one or more gamma aminobutyric acid
5925342 Method for reducing intraocular pressure in the mammalian eye by administration of potassium cha July 20, 1999
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having potass
5891911 Method for reducing intraocular pressure in the mammalian eye by administration of calcium chela April 6, 1999
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains as the active ingredient one or more compounds having calcium
5866605 Method for providing a neuroprotective effect to the mammalian eye by administration of chloride February 2, 1999
Pharmaceutical compositions and a method are disclosed for providing neuroprotective effect to the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having chloride chann
5856329 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury January 5, 1999
A method according to which neuroprotection is conferred upon ocular nerve cells by administration of a drug of formula I to the optic nerve and/or retina of a mammal within a period prior to or following an insult to ocular nerve cells but prior to cell death ##STR1## wherein th
5716952 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic an February 10, 1998
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains as the active ingredient one or more muscarinic antagonist
5705530 Method for reducing intraocular pressure in the mammalian eye by administration of chloride chan January 6, 1998
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having chlori
5677327 Method for identifying muscarinic agents lacking miotic side effects October 14, 1997
The present invention provides a method for identifying a compound having muscarinic agonist activity that will lower intraocular pressure without causing miosis which comprises measuring the activity of the compound at the m.sub.3 and m.sub.5 muscarinic receptors and determining from th
5573758 Method for reducing intraocular pressure in the mammalian eye by administration of potassium cha November 12, 1996
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having potass
5559151 Method for reducing intraocular pressure in the mammalian eye by administration of chloride chan September 24, 1996
Pharmaceutical compositions and a method are disclosed for treating glaucoma and/or ocular hypertension in the mammalian eye by administering to the mammalian eye the pharmaceutical composition of the invention which contains, as the active ingredient, one or more compounds having chlori
5521210 Ophthalmic use of muscarinic agonists having increased duration of activity May 28, 1996
A method for inducing prolonged pseudoaccommodation includes the instillation of an ophthalmic formulation into an eye for contracting the iris sphincter muscle, but not the ciliary muscle, in order to cause sphincter muscle contraction for a period of greater than about one hour per










 
 
  Recently Added Patents
Communication terminal, communication system, server apparatus, and communication connecting method
Immunotherapy in cancer treatment
Image forming apparatus and warming up method thereof
Communications in an asynchronous cellular wireless network
Aspect ratio enhancement
Surveillance apparatus and method for wireless mesh network
Encoding and/or decoding memory devices and methods thereof
  Randomly Featured Patents
DMD Architecture to improve horizontal resolution
Utilization of pyrometer data to detect oxidation
Glass fiberization by centrifugal feed of glass into attenuating blast
Positioning system for rotary folding jaw cylinder adjustment elements in a rotary printing machine
Method for producing light-weight molded articles containing ceramic fibers
Fluid separation element assembly
Phenylaminopyrimidine derivatives and methods of use
System and method for dispatching and scheduling network transmissions with feedback
Adaptive file delivery system and method
Electronic component package and method of manufacturing the same, and electronic component device